Cimeio Therapeutics is an applied gene editing, cellular, and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs for patients with serious and life-threatening diseases.

Biotechnology

Cimeio Therapeutics

Thomas Fuchs

Tanja Herrmann

Saniye Yumlu

Florence Widmann

Stefanie Urlinger

Rosalba Lepore

Thomas Winkler

Daniel Stark

Lukas Jeker

The Board Members at Cimeio Therapeutics provide strategic oversight, governance, and guidance to the company's executive team. They ensure that the company's mission of developing Shielded-Cell & Immunotherapy Pairs is effectively pursued, while also addressing regulatory, financial, and ethical considerations.

Board Members

Scientific Research and Development

Leadership Team

Board Members

About

Team members

Other teams at Cimeio Therapeutics

Scientific Research and Development

Leadership Team